Item 9 Labs Corp. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Miller Ronald L. Jr., was filed 22 Aug 2014.
Item 9 Labs Corp.: what insiders have been doing
Every trade that managers of Item 9 Labs Corp. disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Item 9 Labs Corp. in twelve months, the latest record being from 11 September 2019.
Looking back to 2014, when coverage begins, insiders filed 4 purchases and no sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Since the insiders bought
- +66.7%Entry US$3.00 · Close at T+365 US$5.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2022FY ended September 2022 · cache
- 286,842 shares0CommonSEC:0001554795-19-000314:0
- 360,000 shares0CommonSEC:0001554795-19-000312:0
- 80,000 shares0CommonSEC:0001554795-19-000310:0
- 1,000 shares@ US$0.16Common StockSEC:0001560790-14-000003:0Canonical exit: 17 Nov 2014 (T+90)
- 523 shares@ US$0.16Common StockSEC:0001560790-14-000003:1Canonical exit: 18 Nov 2014 (T+90)
- 4,000 shares@ US$0.17Common StockSEC:0001560790-14-000003:2Canonical exit: 19 Nov 2014 (T+90)
- 21,250 shares@ US$0.12Common StockSEC:0001560790-14-000001:0Canonical exit: 17 Aug 2014 (T+90)
7 of 7 declarations
About Item 9 Labs Corp.
Item 9 Labs Corp. is a company specializing in the production of cannabis-based products. It is listed on the XNAS market.
